Welcome to our dedicated page for Paysign news (Ticker: PAYS), a resource for investors and traders seeking the latest updates and insights on Paysign stock.
Paysign, Inc. (NASDAQ: PAYS) is a fintech and healthcare-focused company whose news flow centers on patient affordability programs, donor compensation solutions and integrated payment processing for the life sciences industries. News about PAYS often highlights developments in its pharma patient affordability business, plasma donor compensation programs and the performance of its card-based payment platform.
Company press releases frequently cover quarterly financial results, where Paysign reports on total revenues, plasma revenue, pharma patient affordability revenue, gross profit, operating expenses, EBITDA and Adjusted EBITDA. These updates also describe trends in plasma center counts, the number of active pharma patient affordability programs, processed claims and the mix of revenue between plasma, pharma patient affordability and other prepaid and incentive programs.
Another recurring theme in Paysign news is the expansion and refinement of its patient affordability solutions. The company has discussed the growth of pharmaceutical copay programs, the adoption of its Dynamic Business Rules technology to address copay maximizers, and the scale of patient and client savings associated with these programs. Announcements have also described the opening of a patient service support center to increase support capacity for the patient affordability business.
Paysign news items also include participation in investor conferences, board and leadership updates and information about engagement and management platforms for life sciences. For investors, analysts and industry participants, the PAYS news page provides a centralized view of earnings releases, operational milestones, program expansions and corporate governance developments tied to the company’s fintech healthcare ecosystem.
Users interested in PAYS can use this news feed to review historical announcements on plasma and pharma program growth, cardholder and program metrics, litigation and settlement updates, and the company’s commentary on its strategic focus within payment processing and healthcare-related markets.
Paysign, Inc. (NASDAQ: PAYS) will present at The Benchmark Company’s 11th Annual Discovery One-on-One Investor Conference on December 1, 2022. The event will take place at the New York Athletic Club, offering a platform for emerging growth companies to connect with institutional investors. Paysign is set to participate in one-on-one meetings throughout the day. Investors interested in scheduling meetings can register online. The company is known for providing prepaid card programs and integrated payment processing services across various industries.
Paysign, Inc. (NASDAQ: PAYS) reported third-quarter 2022 revenues of $10.6 million, up 36% from the previous year. Net income reached $0.85 million, translating to diluted EPS of $0.02. The firm added 13 plasma donation centers in Q3, totaling 450 centers. Gross dollar load volume rose 57.6%, while purchase volume climbed 58.6%. Adjusted EBITDA stood at $1.9 million, reflecting solid operational performance. Looking ahead, total revenue for 2022 is projected between $38.15 million and $38.35 million, indicating 29-30% growth over 2021.
Paysign, Inc. (NASDAQ: PAYS) will report its third quarter 2022 earnings on November 8, 2022, at 5:00 p.m. Eastern time. The company specializes in prepaid card programs, patient affordability, digital banking, and integrated payment solutions. A live webcast will be available for interested parties. The earnings call aims to provide insights into the company’s financial performance and future outlook.
Paysign, Inc. (NASDAQ: PAYS) announced that the U.S. District Court issued a preliminary injunction on September 16, 2022, allowing plasma donations from Mexican nationals on valid B-1/B-2 visas. CEO Mark Newcomer praised the decision, emphasizing its significance for plasma clients and therapies for rare diseases. Paysign is a leader in prepaid card programs and digital banking services, focused on creating innovative payment solutions across various industries.
Paysign, Inc. (NASDAQ: PAYS) will present at the H.C. Wainwright 24th Annual Global Investment Conference from September 12-14, 2022, in New York. CFO Jeff Baker's presentation is scheduled for September 14 at 12:00 p.m. EDT. The investor presentation deck will be available on the investor resources page from September 12. Paysign provides prepaid card programs and digital banking services.
Paysign, Inc. (NASDAQ: PAYS), a key player in prepaid card solutions and digital banking, announced that CEO Mark Newcomer and CFO Jeff Baker will present at the Sidoti Micro-Cap Virtual Investor Conference on August 18, 2022, at 1:00 p.m. EDT. The presentation aims to engage investors, with opportunities for one-on-one meetings. Investors can register for free at sidoti.com/events.
Paysign (NASDAQ: PAYS) reported a strong second quarter, achieving $8.6 million in revenues, up 29% from last year. The net loss decreased to $0.2 million from $0.7 million, with an Adjusted EBITDA of $0.9 million. The company added 62 plasma donation centers this quarter, totaling 437 centers. Plasma revenues increased by 31%, driven by more donations. The outlook remains optimistic, with projected full-year revenue growth of 27.5%. Despite labor shortages and some restrictions, the company anticipates continued improvements.
Paysign, Inc. (NASDAQ:PAYS) announced the resignation of co-founder Daniel H. Spence from its Board of Directors, effective August 8, 2022. He is succeeded by Matthew Lanford, the President and COO, who has extensive experience in the payments industry. CEO Mark Newcomer expressed confidence in Lanford's capabilities to enhance the board's insight. Spence contributed significantly to the company over 21 years, and the transition promises to leverage Lanford's expertise in driving future growth.
Paysign, Inc. (NASDAQ: PAYS) is set to discuss its second quarter 2022 earnings on August 9, 2022, at 5:00 p.m. Eastern time. The company specializes in prepaid card programs, patient affordability offerings, digital banking, and integrated payment processing. Paysign aims to streamline financial operations for various sectors including healthcare and retail. Participants can join via international dial-in or webcast. A replay will be available until November 11, 2022, with further details provided for financial professionals wishing to ask questions.
Paysign reported Q1 2022 revenues of $8.2 million, a 31% increase year-over-year. The net loss decreased to $0.3 million, with adjusted EBITDA rising to $0.9 million. Plasma revenue surged by 37%, driven by increased donations, while pharma revenue saw a slight decline of 9%. The company added 9 new plasma centers, totaling 375. Unrestricted cash increased by $1.1 million to $8.5 million. Full-year guidance remains unchanged, expecting revenue between $35.25 million and $38.35 million.